Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Twist Bioscience Corp (NQ: TWST )

41.21 +9.20 (+28.74%)
Official Closing Price Updated: 4:15 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,490,867
Open 38.28
Bid (Size) 41.25 (18)
Ask (Size) 41.67 (1)
Prev. Close 32.01
Today's Range 35.18 - 41.77
52wk Range 11.92 - 43.21
Shares Outstanding 50,885,068
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Genomics firm Twist Bioscience's Momentum To Continue Throughout 2024, Analyst Says
Twist Bioscience reports strong Q2 earnings, with sales up 25% YoY to $75.3M and orders increasing by 45%. Gross margin expands to 41%. Fiscal year guidance was raised, and William Blair sees continued... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga

Performance

YTD
+18.97%
+18.97%
1 Month
+23.61%
+23.61%
3 Month
+12.63%
+12.63%
6 Month
+120.85%
+120.85%
1 Year
+218.47%
+218.47%

More News

Read More
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
Via Benzinga
TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Analyst Scoreboard: 5 Ratings For Twist Bioscience
Via Benzinga
4 Analysts Have This To Say About Twist Bioscience
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
Via InvestorPlace
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
Via Benzinga
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
Via Benzinga
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Is The Stock Market Ready To Plunge? The Warning Signs Are Here...
Via Talk Markets
7 Stocks Cathie Wood Is Still Loading Up On in Q1
Via InvestorPlace
7 Sexy Stocks That Will Continue to Outperform in 2024
Via InvestorPlace
Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss
Via Benzinga
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
From Twist Bioscience Corporation
Via Business Wire
Why Is DNA Synthesis Company Twist Bioscience Stock Trading Higher Today?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.